CFDE Data Portal | Search EPB42

	Label	Description
	EPB42 Gene (Entity type)	ENSG00000166947 - erythrocyte membrane protein band 4.2
	EPB42 associations Collection (Entity type)	Associations for EPB42_associations
	EPB42 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EPB42 HUMAN Protein (Entity type)	Protein 4.2
	EPB42 MOUSE Protein (Entity type)	Protein 4.2
	EPB42 BOVIN Protein (Entity type)	Protein 4.2
	KFGENEBIN:EPB42-variant-count CUI gene has variants EPB42 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE140322 imatinib K-562 C.M.L. 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115550 BRD4 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

EPB42

ENSG00000166947 - erythrocyte membrane protein band 4.2

EPB42 associations

Associations for EPB42_associations

EPB42 associations.tsv

A file from IDG as part of the Harmonizome project

EPB42 HUMAN

Protein 4.2

EPB42 MOUSE

Protein 4.2

EPB42 BOVIN

Protein 4.2

KFGENEBIN:EPB42-variant-count CUI gene has variants EPB42

A Knowledge Graph Assertion from Kids First

GSE140322 imatinib K-562 C.M.L. 3 v 1 human dn

A Gene Set from LINCS

GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 1 human dn

A Gene Set from LINCS

GSE115550 BRD4 inhibition 2 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.